<?xml version='1.0' encoding='utf-8'?>
<document id="18483837"><sentence text="The quantitative prediction of CYP-mediated drug interaction by physiologically based pharmacokinetic modeling." /><sentence text="The objective is to confirm if the prediction of the drug-drug interaction using a physiologically based pharmacokinetic (PBPK) model is more accurate" /><sentence text=" In vivo Ki values were estimated using PBPK model to confirm whether in vitro Ki values are suitable" /><sentence text="" /><sentence text="The plasma concentration-time profiles for the substrate with coadministration of an inhibitor were collected from the literature and were fitted to the PBPK model to estimate the in vivo Ki values" /><sentence text=" The AUC ratios predicted by the PBPK model using in vivo Ki values were compared with those by the conventional method assuming constant inhibitor concentration" /><sentence text="" /><sentence text="The in vivo Ki values of 11 inhibitors were estimated" /><sentence text=" When the in vivo Ki values became relatively lower, the in vitro Ki values were overestimated" /><sentence text=" This discrepancy between in vitro and in vivo Ki values became larger with an increase in lipophilicity" /><sentence text=" The prediction from the PBPK model involving the time profile of the inhibitor concentration was more accurate than the prediction by the conventional methods" /><sentence text="" /><sentence text="A discrepancy between the in vivo and in vitro Ki values was observed" /><sentence text=" The prediction using in vivo Ki values and the PBPK model was more accurate than the conventional methods" /><sentence text="" /></document>